CLINICAL_TRIALS
trial_result
· 2019-12-04
Clinical Trial Update: Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues [Phase 3]
Summary
Phase 3 trial evaluating pasireotide in patients with acromegaly inadequately controlled by first-generation somatostatin analogues has completed with results p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2019-12-04